Heparin Sodium recalled over sterility concerns
- Recall date
- November 18, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Cantrell Drug Company recalls Heparin Sodium, 1 USP Unit/2 mL (0.5 USP Units/mL) in 0.45% Sodium Chloride, Single-Dose Syringe, Hospital/Office Use O…
- Recall number
- D-0192-2017
- FDA classification
- Class II
- Brand / firm
- Cantrell Drug Company
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Heparin Sodium, 1 USP Unit/2 mL (0.5 USP Units/mL) in 0.45% Sodium Chloride, Single-Dose Syringe, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207, NDC 52533-148-16
Get recall alerts
Free email alert whenever Cantrell Drug Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cantrell Drug Company